UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Valley Brook Capital Group Inc.

Valley Brook Capital Group Inc. lowered its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% in the fourth quarter, according to its most recent disclosure with the SEC. The fund owned 7,088 shares of the healthcare conglomerate’s stock after selling 61 shares during the period. UnitedHealth Group makes up 2.7% of Valley Brook Capital Group Inc.’s investment portfolio, making the stock its 8th biggest holding. Valley Brook Capital Group Inc.’s holdings in UnitedHealth Group were worth $3,586,000 as of its most recent filing with the SEC.

Other hedge funds have also recently added to or reduced their stakes in the company. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group during the fourth quarter worth about $30,000. RPg Family Wealth Advisory LLC bought a new stake in UnitedHealth Group during the third quarter worth about $37,000. Friedenthal Financial bought a new stake in UnitedHealth Group during the third quarter worth about $51,000. DecisionPoint Financial LLC grew its stake in shares of UnitedHealth Group by 155.0% during the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after purchasing an additional 62 shares during the last quarter. Finally, Highline Wealth Partners LLC bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $55,000. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn bought 1,000 shares of the firm’s stock in a transaction that occurred on Friday, January 17th. The stock was acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at approximately $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.33% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on UNH. Bank of America decreased their price target on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating on the stock in a research note on Wednesday, October 16th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research note on Friday, January 10th. Oppenheimer increased their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Cantor Fitzgerald restated an “overweight” rating and issued a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, Royal Bank of Canada cut their price objective on shares of UnitedHealth Group from $615.00 to $595.00 and set an “outperform” rating on the stock in a report on Wednesday, October 16th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Trading Up 0.1 %

Shares of NYSE:UNH opened at $533.99 on Wednesday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company’s fifty day simple moving average is $527.67 and its 200 day simple moving average is $564.22. The firm has a market cap of $491.42 billion, a price-to-earnings ratio of 34.45, a PEG ratio of 1.45 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The firm’s quarterly revenue was up 6.8% on a year-over-year basis. During the same period last year, the business posted $5.83 earnings per share. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.